Betaine prevents Mallory-Denk body formation in drug-primed mice by epigenetic mechanisms

Experimental and Molecular Pathology

Volumn 86, Issue 2, 2009, Pages 77-86

  Oliva, Joan ^a   Bardag Gorce, Fawzia ^a   Li, Jun ^a   French, Barbara A ^a   Nguyen, Sheila K ^a   Lu, Shelly C ^b   French, Samuel W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

BHMT; GNMT; Liver; Mallory Denk body; Methylation

Indexed keywords

BETAINE; BETAINE HOMOCYSTEINE METHYLTRANSFERASE; GLYCINE METHYLTRANSFERASE; METHIONINE; S ADENOSYLHOMOCYSTEINE; ZALCITABINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY BUILD; BODY WEIGHT; CELL PROLIFERATION; ENZYME METABOLISM; EPIGENETICS; GENE EXPRESSION; LIVER CELL; LIVER WEIGHT; MALE; MALLORY DENK BODY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REFEEDING;

ANIMALS; BETAINE; BODY WEIGHT; CARBOXYLIC ACIDS; EPIGENESIS, GENETIC; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; INCLUSION BODIES; LIVER; MALE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S-ADENOSYLMETHIONINE; THIONUCLEOSIDES;

MUS;

EID: 63149110033     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2008.11.002     Document Type: Article

References (32)

1. Avila M.A., et al. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J. Hepatol. 33 (2000) 907-914
2. Bardag-Gorce F., et al. Betaine prevents Mallory-Denk body formation in drug-primed mice. ASSLD. (2008) Poster #363, 133
3. Bardag-Gorce F., et al. Epigenetic mechanisms regulate Mallory Denk body formation in the livers of drug-primed mice. Exp. Mol. Pathol. 84 (2008) 113-121
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
5. Chen Y.M., et al. Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int. J. Cancer. 75 (1998) 787-793
6. Ghoshal K., et al. A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats. J. Nutr. 136 (2006) 1522-1527
7. Huang Z.Z., et al. Changes in methionine adenosyltransferase during liver regeneration in the rat. Am. J. Physiol. 275 (1998) G14-21
8. Huang Z.Z., et al. Differential effect of thioacetamide on hepatic methionine adenosyltransferase expression in the rat. Hepatology 29 (1999) 1471-1478
9. James S.J., et al. Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. J. Nutr. 133 (2003) 3740S-3747S
10. Jenuwein T. The epigenetic magic of histone lysine methylation. FEBS J. 273 (2006) 3121-3135
11. Kotb M., et al. Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet. 13 (1997) 51-52
12. Lee C.G., et al. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 22 (2003) 2592-2603
13. Li J., et al. S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory. Hepatology 47 (2008) 613-624
14. Lu S.C., and Mato J.M. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol 35 (2005) 227-234
15. Lu S.C., and Mato J.M. S-Adenosylmethionine in cell growth, apoptosis and liver cancer. J. Gastroenterol. Hepatol. 23 Suppl. 1 (2008) S73-S77
16. Luka Z., et al. Mutations in human glycine N-methyltransferase give insights into its role in methionine metabolism. Hum. Genet. 110 (2002) 68-74
17. Martinez-Chantar M.L., et al. Methionine adenosyltransferase II beta subunit gene expression provides a proliferative advantage in human hepatoma. Gastroenterology 124 (2003) 940-948
18. Martinez-Chantar M.L., et al. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 47 (2008) 1191-1199
19. Mato J.M., et al. Methionine metabolism and liver disease. Annu. Rev. Nutr. 28 (2008) 273-293 (Review)
20. Mu L.N., et al. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. Cancer Causes Control 18 (2007) 665-675
21. Najm W.I., et al. S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskelet. Disord. 5 (2004) 6
22. Nan L., et al. Mallory body forming cells express the preneoplastic hepatocyte phenotype. Exp. Mol. Pathol. 80 (2006) 109-118
23. Oliva J., et al. Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis. Exp. Mol. Pathol. 84 (2008) 102-112
24. Purohit V., et al. Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am. J. Clin. Nutr. 86 (2007) 14-24
25. Roomi M.W., et al. Preneoplastic liver cell foci expansion induced by thioacetamide toxicity in drug-primed mice. Exp. Mol. Pathol. 81 (2006) 8-14
26. Schwahn B.C., et al. Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. Br. J. Clin. Pharmacol. 55 (2003) 6-13
27. Shechter D., et al. Extraction, purification and analysis of histones. Nat. Protoc. 2 (2007) 1445-1457
28. Torre L., et al. DNA methylation and histone acetylation of rat methionine adenosyltransferase 1A and 2A genes is tissue-specific. Int. J. Biochem. Cell Biol. 32 (2000) 397-404
29. Umlauf D., et al. Site-specific analysis of histone methylation and acetylation. Methods Mol. Biol. 287 (2004) 99-120
30. Vucic E.A., et al. Epigenetics of cancer progression. Pharmacogenomics 9 (2008) 215-234
31. Yang H., et al. The role of c-Myb and Sp1 in the up-regulation of methionine adenosyltransferase 2A gene expression in human hepatocellular carcinoma. FASEB J. 15 (2001) 1507-1516
32. Yuan Q.X., et al. Mallory body induction in drug-primed mouse liver. Hepatology 24 (1996) 603-612